Qianhong Bio-pharma(002550.SZ)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
Qianhong Bio-pharma
002550.SZ
Changzhou Qianhong Biopharma CO.,LTD manufactures and distributes polysaccharide and protease drugs in China. The company offers heparin sodium, heparin calcium, enoxaparin sodium, dalteparin sodium, nadroparin calcium, pancreatin, heparinoid API, kallidinogenase, and asparaginase. It also provides low molecular weight heparin, compound digestive enzyme preparations, and health products. In addition, the company exports its products.
2.788 T
002550.SZMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
B
PharmaceuticalsIndustry
Industry Ranking33/215
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE11.67%B
    • Profit Margin21.84%A
    • Gross Margin61.08%A
  • Growth ScoreD
    • Revenue YoY-2.48%D
    • Net Profit YoY-21.80%D
    • Total Assets YoY9.62%B
    • Net Assets YoY6.65%B
  • Cash ScoreC
    • Cash Flow Margin132.59%B
    • OCF YoY-2.48%D
  • Operating ScoreC
    • Turnover0.48C
  • Debt ScoreA
    • Gearing Ratio11.75%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Qianhong Bio-pharma: The net profit for the third quarter was 125 million yuan, a year-on-year decrease of 1.28%

    Zhitong·
    SZ
    002550
    -2.67%
    Zhitong·
    SZ
    002550
    -2.67%

    Qianhong Bio-pharma: Warned for failing to disclose and halt trading in a timely manner when the shareholding ratio reached the 25% threshold

    Zhitong·
    SZ
    002550
    -2.67%
    Zhitong·
    SZ
    002550
    -2.67%

    Qianhong Bio-pharma released its performance for the first half of the year, with a net profit attributable to the parent company of 258 million yuan, an increase of 41.17%

    Zhitong·
    SZ
    002550
    -2.67%
    Zhitong·
    SZ
    002550
    -2.67%

    Qianhong Bio-pharma shareholder Zhao Gang and his concerted actors plan to reduce their holdings by no more than 20.9 million shares

    Zhitong·
    SZ
    002550
    -2.67%
    Zhitong·
    SZ
    002550
    -2.67%

    The concept of innovative drugs fluctuates and rebounds, ALK hits the limit and reaches a historical high

    Zhitong·
    SZ
    002940
    -4.69%
    SZ
    002550
    -2.67%
    SH
    688319
    -3.76%
    Zhitong·
    SZ
    002940
    -4.69%
    SZ
    002550
    -2.67%
    SH
    688319
    -3.76%
    © 2026 Longbridge｜Disclaimer